Search Results 1091-1100 of 7920 for 不留痕搜索咨询邮箱:lgooxc@hotmail.com
About this study. Primary Objective: Phase 1: To determine the maximum tolerated dose (MTD)/maximum administered dose (MAD) of SAR650984 (Isatuximab).
About this study. The purpose of this study is to evaluate whether or not treatment with alternating 17B-estradiol / anti-estrogen therapies on a defined ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The short-term goal of this study is to inform the process and mechanisms to enrich URM patient accrual to interventional cancer treatment ...
The purpose of this study is to learn more about Lewy Body disease and a skin condition called Bullous Pemphigoid. Participation eligibility. Participant ...
View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.
The purpose of this study is to determine pre-surgical and post-surgical changes in gait stability and free-living activity. The information collected in this ...
This is a Phase III, multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of atezolizumab versus placebo in ...
The purpose of this study is to identify components of the vaginal microbiology environment that contribute to the occurance of preterm labor and preterm ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.